Uromedica, based in Plymouth, MN, is a leading medical company specializing in minimally invasive, adjustable treatment options for stress urinary incontinence (SUI). Their innovative products, ACT and ProACT, are designed to help both men and women reclaim their continence through a simple and effective procedure. With a focus on patient ease of use and safety, Uromedica's treatments offer a passive therapy approach that can be adjusted postoperatively in an office setting, without the need for additional invasive surgeries for removal.
Uromedica's ProACT is specifically designed for men who have SUI as a result of radical prostatectomy or transurethral resection of the prostate, while their ACT system is intended for female patients with stress urinary incontinence resulting from intrinsic sphincter deficiency. With CE Mark approval, Canadian licensing, and availability in Europe, Canada, and Australia, Uromedica's ACT system is making a significant impact in the field of continence treatment.
Generated from the website